ATAP Advocates
Taking a Stand For Patients


News Updates

ATAP Educates Attendees on PBM's at 2019 Cardiovascular Health Policy Summit

Harry Gewanter, M.D., of the Alliance for Transparent & Affordable Prescriptions explained that the “extremely opaque, extremely complex” drug supply chain is part of the problem. Pharmacy benefit managers, the middlemen who manage prescription drug benefits for major health plans, exacerbate the issue. PBMs may make coverage decisions based on what’s financially advantageous to them through the drug rebate system – even if those decisions put patients at risk by complicating access to medicine that prevents heart attack, stroke and death.

Barbara Arnago